(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and ...

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...

The Nunavut government says it will provide immunization against respiratory syncytial virus to all infants in the territory ...

In Singapore’s humid climate, where respiratory illnesses can spread year-round, respiratory syncytial virus (RSV) is ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

RSV is a highly infectious virus that is the most common cause of respiratory infections in children. A free vaccine could ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Wash your hands, learn to cough and sneeze into your elbow, stay home when ill, get a vaccination for flu, COVID and RSV as ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...